Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting
Overview
Social Sciences
Authors
Affiliations
Regular use of colorectal cancer screening can reduce incidence and mortality, but participation rates remain low among low-income, Spanish-speaking Latino adults. We conducted two distinct pilot studies testing the implementation of evidence-based interventions to promote fecal immunochemical test (FIT) screening among Latinos aged 50-75 years who were not up-to-date with CRC screening (n = 200) at a large Federally Qualified Health Center (FQHC) in San Diego, CA. One pilot focused on an opportunistic clinic visit "in-reach" intervention including a 30-min session with a patient navigator, review of an educational "flip-chart," and a take-home FIT kit with instructions. The second pilot was a system-level "outreach" intervention consisting of mailed materials (i.e., FIT kit, culturally and linguistically tailored instructions, and a pre-paid return envelope). Both received follow-up calls to promote screening completion and referrals for additional screening and treatment if needed. The primary outcome was FIT kit completion and return within 3 months assessed through electronic medical records. The in-reach pilot consisted of mostly insured (85%), women (82%), and Spanish-speaking (88%) patients. The outreach pilot consisted of mostly of Spanish-speaking (73%) women (64%), half of which were insured (50%). At a 3-month follow-up, screening completion was 76% for in-reach and 19% for outreach. These data demonstrate that evidence-based strategies to promote CRC screening can be implemented successfully within FQHCs, but implementation (particularly of mailed outreach) may require setting and population-specific optimization. Patient, provider, and healthcare system related implementation approaches and lessons learned from this study may be implemented in other primary care settings.
Zaire P, Miller E, Ewing A, Hefner J, Wright K, Smith L Prev Med Rep. 2025; 49:102954.
PMID: 39834382 PMC: 11743892. DOI: 10.1016/j.pmedr.2024.102954.
Glaser K, Crabtree-Ide C, McNulty A, Attwood K, Flores T, Krolikowski A Int J Environ Res Public Health. 2024; 21(2).
PMID: 38397617 PMC: 10887785. DOI: 10.3390/ijerph21020126.
Davis M, Schneider J, Petrik A, Miech E, Younger B, Escaron A Ann Fam Med. 2022; 20(2):123-129.
PMID: 35346927 PMC: 8959740. DOI: 10.1370/afm.2772.
Source matters: a survey of cost variation for fecal immunochemical tests in primary care.
Coury J, Ramsey K, Gunn R, Judkins J, Davis M BMC Health Serv Res. 2022; 22(1):204.
PMID: 35168616 PMC: 8845335. DOI: 10.1186/s12913-022-07576-4.
Mojica C, Gunn R, Pham R, Miech E, Romer A, Renfro S BMC Cancer. 2022; 22(1):106.
PMID: 35078444 PMC: 8787027. DOI: 10.1186/s12885-021-09106-7.